OpenLB
Open Library of Bioscience
Advanced Search
Personalized medicine
Sep, 2011;8 (5): 495-499.

Personalized medicine for cystic fibrosis: the next generation.

Melissa Ann Ashlock
Author Information
  1. Melissa Ann Ashlock: aTyr Pharma, Inc. 3565 General Atomics Court Suite 103, San Diego, CA 92121, USA. melissaashlock@gmail.com.
PMID: 29793250 DOI: 10.2217/pme.11.52

Abstract

No abstract text available.

Keywords

CFTR VX-770 VX-809 ataluren cystic fibrosis genotype modulator personalized medicine potentiator therapy
Journal Article

Word Cloud

Created with Highcharts 10.0.0medicinecysticPersonalizedfibrosis:nextgenerationCFTRVX-770VX-809atalurenfibrosisgenotypemodulatorpersonalizedpotentiatortherapy

Similar Articles

Cited By